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Numerous studies have demonstrated that chronic bacterial infections in man and 
hyperimmunization of animals lead to  the  occurrence of anti-IgGs in serum  (1-3). 
Rabbits immunized with streptococci produce both 19S and 7S anti-IgGs (4), which 
have specificity for the Fc piece of IgG. The immunological process which leads to the 
occurrence of these anti-IgGs under pathological and experimental conditions has long 
been the source of considerable speculation. One possibility is that anti-IgGs are anti- 
bodies to unidentified bacterial antigens which cross-react with Fc, but this notion 
has received little direct support. The studies reported here are concerned with IgG 
monoclonal components in rabbit antisera which react with IgG as well as bacterial 
cell wall peptidoglycan. 
Peptidoglycan is a  component of the bacterial cell wall composed of hexosa- 
mine polymers with  pentapeptide  side chains  which  are  cross-linked through 
additional peptide chains (5). Previous studies have shown that peptidoglycans 
of the gram-positive cocci are immunogenic. Although both pentapeptide and 
the hexosamine polymer of the peptidoglycan are antigenic determinants,  the 
former is the predominant one (6,  7). Furthermore,  a  recent report has shown 
that  the  C-terminal D-Ala-D-AIa is the immunodominant  antigenic site of the 
pentapeptide  (8).  Immunologic cross-reactions which  have  been  observed be- 
tween  the  peptidoglycans  of  streptococci  and  staphylococci  are  due  to  the 
similarities of the peptide moieties of the two peptidoglycans (9). 
Materials and Methods 
Preparation  of Streptococcal Vaccines, Immunization  of Rabbits,  Quantitative Precipitin 
Analysis for Antibodies to Group-Specific Carbohydrate, and Electrophoretie Methods.--These 
procedures have been previously described  (4, 10, 11). 
Cell Walls.--Cell  walls of Groups  A and  C  streptococci were prepared and purified  by 
the described method (12). 
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Preparation of Peptidoglycan.--The  peptidoglycan of Staphylococcus epidermidis and not 
that of streptococci was used in these studies, because the former has a larger percentage of 
non-cross-linked pentapeptide (13). For this reason it is more reactive as an antigen with the 
peptidoglycan  antibodies in  the  streptococcal  antisera.  The peptidoglycans  of  both strep- 
tococci and staphylococci contain the same pentapeptide.  The cell walls of S.  epidermidis 
strain 24 were extracted with 10% trichloracetic acid at 60°C for 8 h. The residue was termed 
peptidoglycan, and was solubilized by ultrasonic treatment (8). 
Measurement  of  Antipeptidoglycan  Antibody.--The  antipeptidoglycan  antibody  was 
measured with a preeipitin test employing peptidoglycan solubilized by ultrasonic treatment. 
To a series of tubes containing 0.1 ml of a  1:10 dilution of the antiserum were added iflcreas- 
ing amounts of peptidoglycan of S. epldermidis. The precipitates were processed in a fashion 
similar to that used to perform the quantitative precipitin test for the group-specific carbo- 
hydrate (10).  The amount of antipeptidoglycan antibody in the precipitates was calculated 
by subtracting the amount of peptidoglycan from the amount of protein in the precipitate. 
Peptides.--(D-Ala)8 and  (L-Ala)3 were purchased from Cyclo Chemical  Co., Los Angeles, 
Calif.  The  synthesized pentapeptides  L-AIa-D-Glu--r-L-Lys-D-Ala-D-Ala  and Tyr-(Ala)4-Tyr 
were kindly supplied by Dr. K.-H. Schleifer, Botanisches Insfitut der Universitat, Miinchen. 
Measurement of IgG and 7S Anti-IgG.--These methods were previously described in detail 
(4). The radial diffusion technique described by Mancini et ai. (14) was used for the measure- 
ment of IgG. The 7S anti-IgG was quantitated with a  coprecipitation assay which is based 
on the ability of 7S anti-IgG to copreeipitate with antigen-antibody complexes. 
Isolation and Characterization of 7S Anti-IgG.--TS  anti-IgGs were  isolated on immuno- 
absorbent columns and analyzed  on alkaline urea polyacrylamide gels after reduction and 
alkylation according to described methods (15). 
Radioactive Labeling of 7S Anti-IgG.--Isolated  7S anti-IgG was labeled with 1%I according 
to the method of McFarlane (16). 
Inhibition of Coprecipitation A ssay.--The inhibition of the coprecipitation assay to measure 
7S anti-IgG was employed in studies concerning the specificity of the antibody-binding site 
of 7S anti-IgG. In these experiments (a)  the inhibitor, (b) 60/zg of anti-Group A antibody, 
and (c) 10/~g of 125I 7S anti-IgG were incubated for 2 h at 37°C.  Subsequently, 2 #g of Group 
A streptococcal carbohydrate were added and the reaction volume was adjusted with phos- 
phate-buffered saline (PBS) to 0.1 ml. After incubation overnight at 4°C, the tubes were cen- 
trifuged in a Beckman 152 microfuge  (Beckman  Instruments, Inc., Spinco  Div.,  Palo  Alto, 
Calif.), and 0.05 ml was removed with an Eppendorf pipette (Brinkmann Instruments, Inc., 
Westbury, N. Y.)  and placed into another tube. Radioactivity was measured in both tubes 
in a -r-counter and the amount of precipitate was calculated by subtracting the counts in 
the second tube from those of the tube in which the reaction had been performed. The amount 
of radioactivity in the precipitate was expressed in percent of total amount added to the reac- 
tion mixture. Without addition of inhibitors, 25-35% of the radioactivity was found in the 
precipitate. This amount of coprecipitation was  taken as  100% value in the inhibition ex- 
periments. 
Inhibition of the Anti-Idiotype  Reaction.--Anti-idiotype  antibodies to 7S anti-IgG R3387 
raised in guinea pigs were characterized in a previous report (15). The anti-idiotype antiserum 
used  in  these studies maximally precipitated 65% of 125~ 7S  anti-IgG R3387.  For  the  in- 
hibition assay, a  reaction mixture with excess antigen was chosen. In these experiments the 
inhibitor was mixed with 50 #1 of 1:5 diluted antiserum and incubated for 2 h at 37°C.  Sub- 
sequently, 20 ~g 125I 7S anti-IgG was added, and the reaction volume was adjusted  to 0.2 
ml with PBS. Tubes were incubated overnight at 4°C. The zone of excess 12~I anti-IgG was 
selected to minimize the amounts of inhibitor required. This also increased the sensitivity of 
the assay. Under these conditions, without addition of inhibitors, 20% of 7S anti-IgG R3387 
was found in the precipitate after centrifugation in a Beckman 152 microfuge. This amount of 
precipitate was taken as  100% value. 1186  7S  ANTI-IGG  CROSS-REACTING  WITH  PEPTIDOGL¥CAN 
Allotypic  Determination.--Quantitative  measurement of allot3~py on the isolated 7S anti- 
IgGs was done by a modification  of the Mancini et al. (14) method, which employed specific 
allotypic antisera. The allotypic antisera were kindly supplied by Dr. Thomas J. Kindt, The 
Rockefeller University. 
RESULTS 
The four Group C streptococcal antisera listed in Table I  were employed in 
these studies on the relationship between 7S anti-IgG and anti-peptidoglycan 
antibody. These antisera were selected because they all had greater than 6 rag/ 
ml of 7S anti-IgG as detected by a  coprecipitation test (4). A monoclonal 7S 
anti-IgG component could be isolated from each serum by the use of the IgG 
immunoabsorbent column (15). Two antisera had high levels of anti-peptidogly- 
can  antibodies  (6-15 mg/ml)  and  the  other two had  low concentrations  (1- 
2 mg/ml). These four antisera contained between 5 and 23 mg/ml of antibody 
to Group C carbohydrate. 
TABLE  I 
Serum Concentrations of Anti-Peptidoglycan Antibody, Anti-Group  C Carbohydrate, 
and 7S Anti-IgG in Four Group C Antisera 
Serum no.  Total IgG  Anti-group C  Anti-peptidoglycan  antibody  7S anti-IgG  ~ntibody 
mg/ml  ~ng/ml  mg/ml  mg/ml 
R3387  30  5  14.0  15 
R3416  31  13  9.2  6 
R4057  25  11  6.5  2 
R3439  35  23  10.0  1-2 
Peptidoglycan and the Group C carbohydrate are the two major antigens in 
the pepsinized cell walls of Group C  streptococci which were used to test for 
specific antibody activity. The 7S anti-IgG isolated from the four antisera gave 
no reaction with Group C carbohydrate in the capillary precipitin test. The 7S 
anti-IgG of antisera R3387  and R4057,  however, gave  strong  capillary pre- 
cipitin  reactions  with  the  peptidoglycan  while  that  of  antisera  R3416  and 
R3439 did not. Thus, in the case of antisera R3387 and R4057,  the peptido- 
glycan antibody was associated with the  7S  anti-IgG fraction which was  re- 
tarded on the IgG immunoabsorbent column. 
Depicted in  Fig.  1  are  the  quantitative  precipitin  tests for peptidoglycan 
utilizing  whole  antisera,  and  similar  tests  performed  with  the  7S  anti-IgG 
components isolated from these antisera. The 7S anti-IgGs were used at con- 
centrations equivalent to their concentrations in the antisera. Approximately 
70 % of 7S anti-IgG of serum R3387 and 40 % of 7S anti-IgG R4057 precipitated 
with peptidoglycan at equivalence. 
While these results suggest that the 7S anti-IgGs of sera R3387 and R4057 
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FIG.  1.  Quantitative precipitin reaction  between sonically disrupted peptidoglycan of 
S. epidermidis and four Group C anfisera (panel A) and the 7S anti-IgGs isolated from these 
sera (panel B). 
considered. It was possible, for example, that the 7S anti-IgG component which 
was isolated from these sera contained both antibodies to peptidoglycan and 
anti-Fc antibodies, especially since it has been shown that the latter may bind 
soluble IgG (4). This possibility appears less likely for the following reasons. 
First, as depicted in Fig. 2, polyacrylamide disk electrophoresis of the 7S anti- 
IgG components of R3387  and R4057  after reduction and alkylation showed 
only one major light chain band, suggesting the predominance of one antibody 
species.  Second, the isolated 7S anfi-IgG was allotype a2/b4 as determined by 
quantitative tests, although the rabbit R3387  was heterozygous at the a locus, 
a2,  3/b4.  Exclusion of the second group a  allele argues in favor of a  single 
molecular species in the 7S anti-IgG component. Rabbit R4057 was homozygous 
at both the a and b loci, so the allotype of the 7S anti-IgG could not be used to 
judge restricted heterogeneity. Because the supply of 7S  anti-IgG of serum 
R4057 was limited, only 7S anti-IgG of R3387 was employed for the following 
studies. 
Specificity of the Binding Site of 7S Anti-IgG R3387.--Initial  studies on the 
specificity of the 7S anti-IgG R3387  indicated that it reacted with the penta- 
peptide of the peptidoglycan and not with the hexosamine polymer. The reac- 
tion with pentapeptide was examined in greater detail by use of a  synthetic 
pentapeptide, L-Ala-9-Glu-~/-L-Lys-D-Ala-D-Ala, which is identical with that in 
the  peptidoglycan of  streptococci.  The  synthetic pentapepfide,  three  other 
alanine-containing peptides, and IgG were used to inhibit the coprecipitation of 1188  7S  ANTI-IGG CROSS-REACTING  WITH  PEPTIDOGLYCAN 
FIG.  2. Disk electrophoresis in  urea polyacrylamide gel  of reduced and  alkylated  7S 
anti-IgG R3387, R4057, and of pooled rabbit IgG. 
7S anti-IgG with antigen-antibody complexes. In  these experiments, antigen- 
antibody  complexes  were  formed  at  equivalence in  the  presence  of  the  in- 
hibitors and of 1~5I 7S anti-IgG. All inhibitors were used at equal molar con- 
centrations. The results are shown in Fig. 3. 
The synthetic pentapeptide was as effective as IgG in inhibiting the coprecipi- 
tation  between  7S  anti-IgG  R3387 and the  immune complexes. It  should  be 
noted  that  (D-Ala)3 was  inhibitory,  whereas  (L-Ala)3  was not.  Furthermore, 
Tyr-(Ala)4-Tyr, which is completely unrelated to the pentapeptide of peptido- 
glycan, was not inhibitory. 
While definitive studies on the binding affinity of 7S anti-IgG for peptido- 
glycan must employ equilibrium dialysis experiments with radiolabeled penta- 
peptide, preliminary studies suggest that 7S anti-IgG R3387 may have a greater 
affinity for peptidoglycan than  for the antigen-antibody complexes or for an 
IgG immunoabsorbent. To examine this question, the binding of 1~5I anti-IgG 
R3387 to streptococcal cell walls (which have exposed antigenic determinants of 
the peptidoglycan moiety), antigen-antibody complexes, and an IgG immuno- 
absorbent was measured. 
The first set of experiments determined the binding of 1~5I 7S anti-IgG R3387, 
r25I group C  antibody, and lesI preimmune IgG to Groups A and C cell walls. 
0.2 ml of phosphate buffered saline  (PBS)  containing 20 #g of one of the dif- 
ferent ~5I IgG preparations, and 0.1% human serum albumin were added to the 
sediment of 0.4 ml of a  i0 %  cell wall suspension, and incubated overnight at BOKISCH, CHIAO, BERNSTEIN, AND  KRAUSE  1189 
4°C with shaking. The cell walls were centrifuged, washed twice with 3 ml PBS 
and the radioactivity of the pellet was measured. The results of this experiment 
are summarized in Table II. 70-80% of the 7S anti-IgG R3387 was absorbed to 
both Groups A and C cell walls,  even after the washing procedure, whereas less 
than 10% of the 1~5I preimmune IgG was bound. The percent binding of the 7S 
anti-IgG R3387  to  the  cell  walls  compares  favorably to  the  binding  of  '25I 
group C antibody to the group C cell walls. 
In a parallel set of experiments it was observed that 125I anfi-IgG R3387 was 
reversably bound to either preformed complexes consisting of Group A carbo- 
hydrate and anti-Group A antibody, or to IgG coupled to Sepharose. After two 
washes with 3 ml of PBS, less than 10% of the total '25I 7S anti-IgG remained 
bound to the complexes or to the IgG Sepharose. 
Inhibition  of  the  Anti-Idiotype  Reaction  with  Pentapeptide.--Pentapeptide 
inhibits the reaction between 7S anti-IgG R3387  and its anti-idiotype serum. 
.  Tyr-Aia-~-Ala-Tyr 
100-  ~~  L-Ala-L-Ala-L-Ala~ 
80- ~~  -~~a 
='~  20-40"  ~~~Ala-O-Ala 
--..., 
I  I--  I  t-  2  4  6  8 
Inhibitors [nmM] 
FIG. 3.  Inhibition of coprecipitation of 7S anti-IgG R3387 with antigen-antibody corn 
plexes by pentapeptide, (D-Ala)3, (L-Ala)3, Tyr-(Ala)4-Tyr,  and pooled rabbit IgG. 
TABLE II 
Binding to Streptococcal Cell Walls of 7S A,ti-lgG R3387 and 
Group C Antibodies Isolated  from Antiserum 
IgG 
Streptococcal cell walls 
Group A  Group C 
%*  %* 
7S anti-IgG R3387  68  81 
Anti-Group C antibody  12  91 
Preimmune IgG  6.5  7 
* The percent of total fraction added which was recovered from cell walls after washing. 





Anti-idiotype antibodies were raised in guinea pigs and made monospecific by 
absorption with pooled rabbit IgG coupled to Sepharose. A  precipitin curve 
was  established  by  adding  increasing  amounts  of  anti-idiotype  serum  to  a 
series of tubes  containing 10 #g  12~I-labeled 7S  anti-IgG R3387.  65%  of 12~I- 
labeled 7S anti-IgG R3387 precipitated even in the presence of excess antibody. 
Conditions  of  antigen  excess  were  chosen  for  inhibition  experiments.  The 
pentapeptide and the (L-Ala)3 peptide were used as inhibitors. The results of 
these experiments are depicted in Fig. 4. The pentapeptide inhibited the anti- 
idiotype reaction whereas  (L-Ala)3 had no effect. This is  additional  evidence 
that  the  7S  anti-IgG R3387  has  specificity for the pentapeptide of peptido- 
glycan. 
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Fro. 4. Inhibition of the precipitin reaction between 7S anti-IgG R3387 and its  anti- 
idiotype antiserum by the pentapeptide. 
DISCUSSION 
The antisera of rabbits immunized with Groups A, A-variant, and C strepto- 
cocci often contain  7S  anti-IgGs  and  antibodies  to the peptidoglycan of the 
bacterial  cell wall,  in  addition  to the  antibodies  to the group-specific carbo- 
hydrates. The specificity of the 7S anti-IgGs of four different Group C antisera, 
isolated by means of an IgG immunoabsorbent column, has been examined in 
greater detail here. From two of these antisera, the isolated component reacted 
with (a) antigen-antibody complexes in a coprecipitation test which is used to 
detect the 7S anti-IgGs and (b) the peptidoglycan of the cell wall. For the other 
two antisera, the isolated 7S anti-IgG components did not react with peptido- 
glycan; thus,  the  antibodies  to peptidoglycan in  the latter  two  antisera  are 
distinct from 7S anti-IgG. 
The 7S anti-IgG isolated from rabbit streptococcal antisera R3387 and R4057 
was  homogeneous by several criteria.  Previous studies  have  shown  that  the 
activity of 7S  anti-IgG was directed toward  the  Fc portion of IgG  (15). In 
addition, these 7S anti-IgG components gave a precipitin reaction with strepto- BOKISCH,  CHIAO,  BERNSTEIN,  AND  KRAUSE  1191 
coccal cell wall peptidoglycan. Inhibition of the coprecipitation of 7S anti-IgG 
R3387  with  antigen-antibody complexes  by  the  pentapeptide,  L-Ala-D-Glu- 
3,-L-Lys-D-Ala-D-Ala, of peptidoglycan and also by (n-Ala), suggests that the 
7S anti-IgG reacts with the immunodominant C-terminal D-Ala-D-Ala antigenic 
determinant of the pentapeptide just as do the previously described antibodies 
to peptidoglycan of streptococcal antisera (7,  8). The two specificities of this 
homogeneous 7S anti-IgG, one for the C-terminal sequence of pentapeptide in 
peptidoglycan, and the other for the Fc portion of IgG, are difficult to reconcile 
from an immunochemical point of view. Unusual cross-reactions of a  similar 
sort have been reported by Hannestad (17) who described a polyclonal human 
19S  rheumatoid factor which reacted with TNP,  and a Waldenstr~Sm macro- 
globulin with anti-IgG activity which precipitated denatured DNA. 
Additional support for the view that the homogeneous 7S anti-IgG component 
of serum R3387 may be an antibody to peptidoglycan stems from the idiotypic 
studies.  The  precipitin  reaction  between  this  antibody  component  and  its 
idiotypic antiserum was inhibited by the pentapeptide. Such an observation is 
in keeping with the view that the idiotypic determinant includes the binding 
site of the  antibody. Haptenic inhibition of the  idiotypic reaction has been 
observed in other antigen-antibody reactions (18-20). 
The  occurrence  of  an  antibody component in  streptococcal  antisera  with 
specificity for both the Fc of IgG and the pentapeptide of peptidoglycan raises 
a question about the identity of the stimulating antigen. Is such an antibody 
component, which occurs as a result of this immunization procedure, primarily 
an autoantibody, or is it an antibody to the peptidoglycan of the bacterial vac- 
cine,  an  antibody which incidentally cross-reacts with Fc? One possible  ap- 
proach to this question is to examine the binding affinity of this antibody for 
these two antigens. While this question requires further study, the preliminary 
results reported here raise the possibility that the  7S  anti-IgG R3387  has a 
greater affinity for peptidoglycan than for antigen-antibody complexes or an 
IgG immunoabsorbent. Such a finding suggests that the term 7S anti-IgG is a 
misnomer for the antibody component isolated from'antiserum R3387  by the 
IgG immunoabsorbent column. Rather, the evidence suggests this homogeneous 
IgG component was produced primarily as antibody to peptidoglycan. Such an 
interpretation  based  only on binding  affinity data must,  of  course,  be  cor- 
roborated by additional approaches. 
Several lines of evidence indicate that the occurrence of anti-IgGs in rabbits 
depends on  the nature  of  the  immunizing antigen. Whereas  all  rabbits  im- 
munized  with  streptococcal  vaccines  produced  anti-IgGs,  those  immunized 
with pneumococcal vaccine were  less  likely to  do  so  (4).  Furthermore,  the 
streptococcal vaccines vary in their efficacy in stimulating the occurrence of 
anti-IgGs. A  survey of many antisera revealed that the concentration of 7S 
anti-IgGs in the Group A-variant sera were on the average higher than in the 
Groups A or C antisera.  1 In this connection, it should be noted that Group A- 
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variant  antisera  usually  have  the  highest  titers  of  anti-peptidoglycan  anti- 
bodies (21). Future studies on the origin of anti-IgGs may be facilitated by the 
use of A-variant rabbit antisera. 
Other possible avenues should be explored for an association between anti- 
bodies to peptidoglycan and anti-IgGs. For example, Williams and Kunkel have 
noted the common occurrence of rheumatoid factors in patients with subacute 
endocarditis (22). Unusually high latex fixation titers were observed in patients 
infected with a-streptococci. The work presented here raises the possibility that 
such anti-IgGs may be cross-reactive with bacterial peptidoglycans. In another 
line of investigation, Braun  and Hohn (23), by use of Ouchterlony analysis, 
reported that 75 % of the sera from patients with rheumatoid arthritis contained 
antibodies to peptidoglycan, whereas 16% of the sera from patients with acute 
poststreptococcal  glomerulonephritis  had  detectable  peptidoglycan  anti- 
bodies. The influence of rheumatoid factors in the detection of these antibodies 
has yet to be assessed. These questions can be examined further by the measure- 
ment of peptidoglycan antibodies in sera of patients with a radioimmunoassay 
currently under development. 
SUMMARY 
The relationship between  7S  anti-IgG  and  antibodies  to streptococcal cell 
wall  peptidoglycan  was  examined  for  four  streptococcal  Group  C  antisera. 
Homogeneous 7S anti-IgG components in these sera were isolated by means of 
an  IgG  immunoadsorbent  column.  For  two  of  the  four  antisera,  the  anti- 
peptidoglycan activity of the 7S anti-IgG had specificity for the pentapeptide, 
L-AIa-D-Glu-q,-L-Lys-D-Ala-D-Ala,  the antigenic determinant of peptidoglycan, 
as well as for the Fc of IgG. Detailed studies on the 7S anti-IgG from one of the 
antisera revealed that the pentapeptide inhibited the coprecipitation reaction 
of  7S  anti-IgG  R3387  with  antigen-antibody  complexes  and  the  precipitin 
reaction between 7S anti-IgG R3387 and its anti-idiotype serum. 
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